Home › Therapeutic areas › Oncology › Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (5 companies)
Companies with an active program in Diffuse Large B-Cell Lymphoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ADCT | ADC Therapeutics | Oncology | 1 | Approved | 5 |
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | 12 |
| FHTX | Foghorn Therapeutics | Oncology | 1 | Phase 1 | 5 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 1 | Phase 3 | 16 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 36 |
No companies match.